{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:02:13Z","timestamp":1790017333673,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015956","name":"Special Project for Research and Development in Key areas of Guangdong Province","doi-asserted-by":"publisher","award":["2019B020209001"],"award-info":[{"award-number":["2019B020209001"]}],"id":[{"id":"10.13039\/501100015956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ijrobp.2022.07.009","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T22:12:20Z","timestamp":1658355140000},"page":"433-443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Efficacy of Thymosin \u03b11 in Management of Radiation Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiotherapy: A Phase 2 Clinical Trial (GASTO-1043)"],"prefix":"10.1016","volume":"114","author":[{"given":"Fangjie","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoting","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naibin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3335-3756","authenticated-orcid":false,"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2022.07.009_bib0001","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.3109\/0284186X.2012.747696","article-title":"Predictors of grade \u22652 and grade \u22653 radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with three-dimensional conformal radiotherapy","volume":"52","author":"Dang","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0002","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20130562","article-title":"Simultaneous integrated boost intensity-modulated radiotherapy for treatment of locally advanced non-small-cell lung cancer: A retrospective clinical study","volume":"87","author":"Ji","year":"2014","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0003","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/0360-3016(94)00429-O","article-title":"Injury to the lung from cancer therapy: Clinical syndromes, measurable endpoints, and potential scoring systems","volume":"31","author":"McDonald","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0004","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0360-3016(03)01614-6","article-title":"Increased IL-6 and TGF-beta1 concentrations in bronchoalveolar lavage fluid associated with thoracic radiotherapy","volume":"58","author":"Barthelemy-Brichant","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0005","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ijrobp.2003.09.045","article-title":"Target cells in radiation pneumopathy","volume":"58","author":"Trott","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0006","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002421","article-title":"Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy","volume":"9","author":"Cortellini","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0008","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12957-021-02321-3","article-title":"Risk factors for radiation-induced lung injury in patients with advanced non-small cell lung cancer: Implication for treatment strategies","volume":"19","author":"Sha","year":"2021","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0009","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/jn\/128.10.1661","article-title":"Vitamin A inhibits radiation-induced pneumonitis in rats","volume":"128","author":"Redlich","year":"1998","journal-title":"J Nutr"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0010","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.4155\/fmc-2019-0162","article-title":"Prevention and treatment of radiation-induced lung injury","volume":"12","author":"Xia","year":"2020","journal-title":"Future Med Chem"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0011","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.peptides.2010.07.026","article-title":"Thymosin alpha 1: Biological activities, applications and genetic engineering production","volume":"31","author":"Li","year":"2010","journal-title":"Peptides"},{"issue":"Sup 1","key":"10.1016\/j.ijrobp.2022.07.009_bib0012","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/14712598.2018.1474197","article-title":"Serum thymosin alpha 1 levels in normal and pathological conditions","volume":"18","author":"Pica","year":"2018","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0013","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.transproceed.2006.10.005","article-title":"Immunoregulation of thymosin alpha 1 treatment of cytomegalovirus infection accompanied with acute respiratory distress syndrome after renal transplantation","volume":"39","author":"Ji","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0014","doi-asserted-by":"crossref","first-page":"ofaa588","DOI":"10.1093\/ofid\/ofaa588","article-title":"Thymosin alpha 1 mitigates cytokine storm in blood cells from coronavirus disease 2019 patients","volume":"8","author":"Matteucci","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0015","doi-asserted-by":"crossref","first-page":"R8","DOI":"10.1186\/cc11932","article-title":"The efficacy of thymosin alpha 1 for severe sepsis (ETASS): A multicenter, single-blind, randomized and controlled trial","volume":"17","author":"Wu","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0016","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/carcin\/bgab082","article-title":"Association between previous lung diseases and lung cancer risk: A systematic review and meta-analysis","volume":"42","author":"Ang","year":"2021","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0017","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s12072-012-9386-z","article-title":"Erratum to: Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update","volume":"6","author":"Liaw","year":"2012","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0018","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1182\/blood-2003-11-4036","article-title":"Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling","volume":"103","author":"Romani","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0019","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/1040841X.2016.1176988","article-title":"Gut-lung axis: The microbial contributions and clinical implications","volume":"43","author":"He","year":"2017","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature18848","article-title":"The microbiota in adaptive immune homeostasis and disease","volume":"535","author":"Honda","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0021","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.prro.2021.06.004","article-title":"Hypofractionated intensity modulated radiation therapy with concurrent chemotherapy in locally advanced non-small cell lung cancer: A phase II prospective clinical trial (GASTO1011)","volume":"11","author":"Qiu","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0022","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/s41587-019-0252-6","article-title":"Author correction: Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2","volume":"37","author":"Bolyen","year":"2019","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0023","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nmeth.3869","article-title":"DADA2: High-resolution sample inference from Illumina amplicon data","volume":"13","author":"Callahan","year":"2016","journal-title":"Nat Methods"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0024","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.lungcan.2020.05.035","article-title":"Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"146","author":"Jung","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/ijms20010024","article-title":"Combining radiotherapy and immunotherapy in lung cancer: Can we expect limitations due to altered normal tissue toxicity?","volume":"20","author":"Wirsd\u00f6rfer","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0026","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2217\/fon-2020-0754","article-title":"The right immune-modulation at the right time: Thymosin \u03b11 for prevention of severe COVID-19 in cancer patients","volume":"17","author":"Bersanelli","year":"2021","journal-title":"Future Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0027","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/0885066608326970","article-title":"A new immunomodulatory therapy for severe sepsis: Ulinastatin plus thymosin {alpha} 1","volume":"24","author":"Li","year":"2009","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0028","article-title":"Efficacy of thymosin alpha 1 in the treatment of COVID-19: A multicenter cohort study","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0029","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12890-020-01376-4","article-title":"Radiation-induced lung injury: Current evidence","volume":"21","author":"Arroyo-Hern\u00e1ndez","year":"2021","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1749-6632.1979.tb47100.x","article-title":"T-lymphocyte maturation: Cell surface markers and immune function induced by T-lymphocyte cell-free products and thymosin polypeptides","volume":"332","author":"Ahmed","year":"1979","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0031","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.cellbi.2008.07.011","article-title":"Effects of thymic polypeptides on the thymopoiesis of mouse embryonic stem cells","volume":"32","author":"Peng","year":"2008","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0032","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1586\/14787210.3.6.885","article-title":"Thymalfasin for the treatment of chronic hepatitis C infection","volume":"3","author":"Rustgi","year":"2005","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0033","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1749-6632.2010.05486.x","article-title":"Thymosin alpha1 to harness immunity to pathogens after haploidentical hematopoietic transplantation","volume":"1194","author":"Perruccio","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0034","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.radonc.2021.01.034","article-title":"Risk and impact of radiation related lymphopenia in lung cancer: A systematic review and meta-analysis","volume":"157","author":"Upadhyay","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0035","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ijrobp.2019.08.047","article-title":"Impact of treatment-related lymphopenia on immunotherapy for advanced non-small cell lung cancer","volume":"105","author":"Cho","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0036","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1749-6632.2012.06707.x","article-title":"Thymosin \u03b11 as a stimulatory agent of innate cell-mediated immune response","volume":"1270","author":"Serafino","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0037","article-title":"The efficacy and safety of epidermal growth factor receptor tyrosine kinase inhibitor combined with thymosin in advanced non-small cell lung cancer patients harboring active epidermal growth factor receptor mutations","volume":"11","author":"Feng","year":"2021","journal-title":"Front Oncol"},{"issue":"Sup 1","key":"10.1016\/j.ijrobp.2022.07.009_bib0038","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/14712598.2018.1484104","article-title":"Thymosin alpha 1 treatment for patients with sepsis","volume":"18","author":"Pei","year":"2018","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0039","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.3748\/wjg.v12.i41.6715","article-title":"Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: A randomized controlled study","volume":"12","author":"You","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0040","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/oxfordjournals.annonc.a058979","article-title":"Biochemotherapy with thymosin alpha 1, interleukin-2 and dacarbazine in patients with metastatic melanoma: Clinical and immunological effects","volume":"5","author":"Lopez","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0041","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1200\/JCO.2009.25.5208","article-title":"Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanoma","volume":"28","author":"Maio","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0042","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/jps.10401","article-title":"Long-term outcomes of thymosin-alpha 1 and interferon alpha-2b combination therapy in patients with hepatitis B e antigen (HBeAg) negative chronic hepatitis B","volume":"92","author":"Saruc","year":"2003","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0043","doi-asserted-by":"crossref","first-page":"e12966","DOI":"10.1111\/cmi.12966","article-title":"The role of the lung microbiota and the gut-lung axis in respiratory infectious diseases","volume":"20","author":"Dumas","year":"2018","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104062","article-title":"The distribution characteristics of intestinal microbiota in children with community-acquired pneumonia under five years of age","volume":"142","author":"Ren","year":"2020","journal-title":"Microb Pathog"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0045","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fimmu.2018.00182","article-title":"Respiratory disease following viral lung infection alters the murine gut microbiota","volume":"9","author":"Groves","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0046","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.micinf.2015.10.008","article-title":"Control of Klebsiella pneumoniae pulmonary infection and immunomodulation by oral treatment with the commensal probiotic Bifidobacterium longum 5(1A)","volume":"18","author":"Vieira","year":"2016","journal-title":"Microbes Infect"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1348-0421.12210","article-title":"Consecutive oral administration of Bifidobacterium longum MM-2 improves the defense system against influenza virus infection by enhancing natural killer cell activity in a murine model","volume":"59","author":"Kawahara","year":"2015","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0048","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s40487-021-00171-3","article-title":"Response to PD-1-based immunotherapy for non-small cell lung cancer altered by gut microbiota","volume":"9","author":"He","year":"2021","journal-title":"Oncol Ther"},{"key":"10.1016\/j.ijrobp.2022.07.009_bib0049","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1093\/annonc\/mdz224","article-title":"Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab","volume":"30","author":"Chaput","year":"2019","journal-title":"Ann Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622007283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301622007283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:01:20Z","timestamp":1759744880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301622007283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0360301622007283"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.07.009","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Thymosin \u03b11 in Management of Radiation Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiotherapy: A Phase 2 Clinical Trial (GASTO-1043)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2022.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}